Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
DURHAM, N.C., May 13, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today reported financial results for the quarter ended March 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
